L. Pemberton

551 total citations
34 papers, 321 citations indexed

About

L. Pemberton is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Radiation. According to data from OpenAlex, L. Pemberton has authored 34 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Radiation. Recurrent topics in L. Pemberton's work include Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (7 papers) and Advanced Radiotherapy Techniques (6 papers). L. Pemberton is often cited by papers focused on Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (7 papers) and Advanced Radiotherapy Techniques (6 papers). L. Pemberton collaborates with scholars based in United Kingdom, Australia and United States. L. Pemberton's co-authors include Brian Magee, H. Rao Gattamaneni, M Dougal, Andrew Sykes, R. Swindell, M. Hatton, Omar Din, Corinne Faivre‐Finn, David Gilligan and N. Bayman and has published in prestigious journals such as Journal of Clinical Oncology, Radiotherapy and Oncology and Journal of Thoracic Oncology.

In The Last Decade

L. Pemberton

29 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Pemberton United Kingdom 9 166 78 68 64 59 34 321
Edward Yu Canada 13 249 1.5× 143 1.8× 12 0.2× 66 1.0× 36 0.6× 27 434
Sebastian M. Christ Switzerland 9 116 0.7× 57 0.7× 6 0.1× 75 1.2× 53 0.9× 40 247
Chance Matthiesen United States 9 84 0.5× 43 0.6× 29 0.4× 45 0.7× 30 0.5× 25 262
Kevin A. Pearlstein United States 10 161 1.0× 64 0.8× 6 0.1× 100 1.6× 61 1.0× 23 339
Elizabeth Maher United Kingdom 7 111 0.7× 85 1.1× 17 0.3× 51 0.8× 70 1.2× 10 301
Erkan Kaba Türkiye 9 264 1.6× 36 0.5× 17 0.3× 39 0.6× 91 1.5× 52 325
A. León Martín Spain 11 75 0.5× 40 0.5× 23 0.3× 28 0.4× 27 0.5× 26 364
Aydın Yavuz Türkiye 10 130 0.8× 81 1.0× 14 0.2× 44 0.7× 92 1.6× 33 326
You Jin Ku South Korea 9 59 0.4× 69 0.9× 30 0.4× 6 0.1× 99 1.7× 27 383
U. Tiefenbacher Germany 9 188 1.1× 93 1.2× 46 0.7× 80 1.3× 144 2.4× 13 367

Countries citing papers authored by L. Pemberton

Since Specialization
Citations

This map shows the geographic impact of L. Pemberton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Pemberton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Pemberton more than expected).

Fields of papers citing papers by L. Pemberton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Pemberton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Pemberton. The network helps show where L. Pemberton may publish in the future.

Co-authorship network of co-authors of L. Pemberton

This figure shows the co-authorship network connecting the top 25 collaborators of L. Pemberton. A scholar is included among the top collaborators of L. Pemberton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Pemberton. L. Pemberton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Banfill, Kathryn, N. Bayman, Margaret Harris, et al.. (2025). Integrating Electronic Patient-Reported Outcome Measures (ePROMs) into Personalised Follow-up for Patients after Radiotherapy. A Feasibility Study. Technical Innovations & Patient Support in Radiation Oncology. 35. 100333–100333.
2.
Banfill, Kathryn, Claire Barker, N. Bayman, et al.. (2025). 2469 Reirradiation for Lung Cancer: Investigating Toxicity and Outcomes. Radiotherapy and Oncology. 206. S1355–S1357.
3.
Pemberton, L., et al.. (2024). Understanding organisational and nursing behaviour changes associated with a therapeutic engagement improvement tool in acute mental health inpatient settings: A qualitative analysis. International Journal of Nursing Studies Advances. 6. 100180–100180. 2 indexed citations
4.
Phiri, Peter, et al.. (2024). Tree: Reducing the use of restrictive practices on psychiatric wards through virtual reality immersive technology training. World Journal of Psychiatry. 14(10). 1521–1537.
5.
Fornacon-Wood, Isabella, Clara C. Chan, N. Bayman, et al.. (2022). Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer. Frontiers in Oncology. 12. 835844–835844. 7 indexed citations
6.
Pemberton, L., et al.. (2022). Barriers and enablers to implementation of the therapeutic engagement questionnaire in acute mental health inpatient wards in England: A qualitative study. International Journal of Mental Health Nursing. 31(6). 1467–1479. 4 indexed citations
7.
Mistry, Hitesh, N. Bayman, Clara C. Chan, et al.. (2021). Outcomes of curative-intent radiotherapy in non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). Radiotherapy and Oncology. 160. 78–81. 9 indexed citations
8.
Bayman, N., Margaret Harris, L. Pemberton, et al.. (2021). Routine electronic patient reported outcomes measures (ePROMs) for patients with lung cancer. Lung Cancer. 156. S6–S6. 1 indexed citations
9.
Kennedy, Jason, Gareth Price, David Woolf, et al.. (2020). Palliative Lung Radiotherapy: Higher Dose Leads to Improved Survival?. Clinical Oncology. 32(10). 674–684. 9 indexed citations
10.
Pemberton, L., et al.. (2020). Practitioners’ experiences of using Gut Directed Hypnosis for irritable bowel syndrome: Perceived impact upon client wellbeing: A qualitative study. Complementary Therapies in Medicine. 55. 102605–102605. 2 indexed citations
11.
Woolf, David, N. Bayman, Margaret Harris, et al.. (2018). The use of volunteers to implement electronic patient reported outcomes in lung cancer outpatient clinics. Technical Innovations & Patient Support in Radiation Oncology. 7. 11–16. 3 indexed citations
12.
13.
Christodoulou, Maria, N. Bayman, P.A. Burt, et al.. (2014). Investigation of a Patient Reported Outcome tool to assess radiotherapy-related toxicity prospectively in patients with lung cancer. Radiotherapy and Oncology. 112(2). 244–249. 20 indexed citations
14.
Din, Omar, Susan Harden, Emma Hudson, et al.. (2013). Accelerated hypo-fractionated radiotherapy for non small cell lung cancer: Results from 4 UK centres. Radiotherapy and Oncology. 109(1). 8–12. 57 indexed citations
15.
Pemberton, L., N. Bayman, Yvonne Summers, et al.. (2013). 103 Do treatment decisions made at lung cancer multi-disciplinary team meetings (MDTs) reflect the actual treatment given in practice?. Lung Cancer. 79. S36–S36. 3 indexed citations
16.
Faivre‐Finn, Corinne, P.A. Burt, Margaret Harris, et al.. (2012). 89 Management of stage III non-small-cell lung cancer (NSCLC) in the Greater Manchester and Cheshire Cancer Network (GMCCN): an analysis of current practice. Lung Cancer. 75. S30–S30. 1 indexed citations
17.
Pemberton, L., Omar Din, P.M. Fisher, & M. Hatton. (2008). Accelerated Radical Radiotherapy for Non-small Cell Lung Cancer using Two Common Regimens: a Single-centre Retrospective Study of Outcome. Clinical Oncology. 21(3). 161–167. 18 indexed citations
18.
Pemberton, L., R. Swindell, & Andrew Sykes. (2006). Primary Radical Radiotherapy for Squamous Cell Carcinoma of the Middle Ear and External Auditory Canal — an Historical Series. Clinical Oncology. 18(5). 390–394. 40 indexed citations
19.
Pemberton, L., et al.. (2006). Adjuvant Chemoradiotherapy for Gastric Carcinoma: Dosimetric Implications of Conventional Gastric Bed Irradiation and Toxicity. Clinical Oncology. 18(9). 663–668. 6 indexed citations
20.
Pemberton, L., M Dougal, Brian Magee, & H. Rao Gattamaneni. (2005). Experience of external beam radiotherapy given adjuvantly or at relapse following surgery for craniopharyngioma. Radiotherapy and Oncology. 77(1). 99–104. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward Yu Breakdown of academic impact, for papers by Sebastian M. Christ Breakdown of academic impact, for papers by Chance Matthiesen Breakdown of academic impact, for papers by Kevin A. Pearlstein Breakdown of academic impact, for papers by Elizabeth Maher Breakdown of academic impact, for papers by Erkan Kaba Breakdown of academic impact, for papers by A. León Martín Breakdown of academic impact, for papers by Aydın Yavuz Breakdown of academic impact, for papers by You Jin Ku Breakdown of academic impact, for papers by U. Tiefenbacher
Rankless by CCL
2026